FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Carisoprodol Tablets Recall

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class III
Reported by FDA
Mar 19, 2014
Recall ID
D-1155-2014
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Carisoprodol Tablets starting Jan 28, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1155-2014 on Mar 19, 2014. Reason: Failed Impurity/degradation Specification. Status: Terminated.

Why it was recalled

Failed Impurity/degradation Specification

Product description

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

Lot numbers, UPCs & expiration codes

Lots and Expiration Dates: 3037463, Expires 2/2014; 3039466, Expires 3/2014; 3040644, Expires 4/2014; 3043463, Expires 6/2014; 3049568, Expires 3/2015

Where it was sold

US: Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1155-2014
Classification
Class III
Status
Terminated
Recall initiated
Jan 28, 2014
FDA report date
Mar 19, 2014
Quantity
3,252 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-1155-2014, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
67393
Address
1718 Northrock Ct
Code information
Lots and Expiration Dates: 3037463, Expires 2/2014; 3039466, Expires 3/2014; 3040644, Expires 4/2014; 3043463, Expires 6/2014; 3049568, Expires 3/2015
Postal code
61103-1201
Report date
Mar 19, 2014
Product type
Drugs
Recall number
D-1155-2014
Classification
Class III
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
3,252 cartons
Termination date
Jun 19, 2015
Reason for recall
Failed Impurity/degradation Specification
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20
Distribution pattern
US: Nationwide
Recall initiation date
Jan 28, 2014
Initial firm notification
Letter
Center classification date
Mar 12, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1155-2014, published Mar 19, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls